2020_9470 defense
2020_9470 defense
TECHNOLOGY
…Only the best is good for Bells.
OTA, NIGERIA
(2020/9470)
COMPUTER ENGINEERING
www.bellsuniversity.edu.n
OUTLINE
Introduction
Literature Review
Methodology
Expected Contribution to Knowledge
Expected Result
cancer (NSCLC) and small cell lung cancer (SCLC),affecting critical functions.
• Machine Learning (ML) : A subfield of artificial intelligence that uses statistical methods to enable machines
• CT Scan (Computed Tomography): An imaging technique that uses X-rays to create detailed cross-sectional
• Lung cancer continues to present a significant challenge in early detection due to the absence of
noticeable symptoms at the onset of the disease and the limitations of current diagnostic
techniques.
• Traditional diagnostic methods, such as CT scans and X-rays, rely heavily on human
interpretation, which can lead to variability in results, missed diagnoses, and delayed treatment.
• There is a need for models that are data-efficient, accurate, and interpretable which is what this
study focuses on.
12/16/2024
www.bellsuniversity.edu.n
PROPOSED METHODOLOGY
Model
Data Collection Preprocessing
Development
Deployment and
Future Integration and Validation and
Improvements Interpretation Testing
• Traditional ML models: Implement Random Forest and SVM for clinical data.
• Evaluate performance using metrics like accuracy, precision, recall, and F1-score.
• Use interpretable AI methods (e.g., SHAP values) to highlight key predictive factors.
• Provide insights for clinicians by integrating the model with clinical decision-support systems.
• Regularly update the model with new data for continuous learning and performance enhancement.Provide insights for clinicians by integrating
the model with clinical decision-support systems.
• Multi-Modal Data Integration: Combining imaging, clinical, and genetic data offers a holistic approach to cancer
• Practical Applicability: Interpretable AI techniques make machine learning models more accessible and reliable for clinical
use.
• Support for Personalized Medicine: The framework facilitates individualized screening and risk assessments, aligning with
12/16/2024